Vaughn CB - Search Results

1

Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.

Mowla A, Sharifian-Dorche M, Mehla S, Lail NS, Sharifian-Dorche A, Vaughn CB, Sawyer RN, Shirani P. Mowla A, et al. Among authors: vaughn cb. J Neurol Sci. 2021 Jun 15;425:117451. doi: 10.1016/j.jns.2021.117451. Epub 2021 Apr 15. J Neurol Sci. 2021. PMID: 33882341

2

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.

Gaindh D, Kavak KS, Teter B, Vaughn CB, Cookfair D, Hahn T, Weinstock-Guttman B; New York State Multiple Sclerosis Consortium. Gaindh D, et al. Among authors: vaughn cb. J Neurol Sci. 2016 Nov 15;370:13-17. doi: 10.1016/j.jns.2016.09.005. Epub 2016 Sep 9. J Neurol Sci. 2016. PMID: 27772741

3

Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.

Mowla A, Kamal H, Lail NS, Vaughn C, Shirani P, Mehla S, Rajabzadeh-Oghaz H, Deline C, Ching M, Crumlish A, Sawyer RN. Mowla A, et al. J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1414-1418. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.021. Epub 2017 Apr 21. J Stroke Cerebrovasc Dis. 2017. PMID: 28438515

4

Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis.

Mowla A, Shah H, Lail NS, Vaughn CB, Shirani P, Sawyer RN. Mowla A, et al. Among authors: vaughn cb. Cerebrovasc Dis. 2020;49(5):503-508. doi: 10.1159/000510095. Epub 2020 Sep 14. Cerebrovasc Dis. 2020. PMID: 32927457

5

Does Body Mass Index Impact the Outcome of Stroke Patients Who Received Intravenous Thrombolysis?

Zambrano Espinoza MD, Lail NS, Vaughn CB, Shirani P, Sawyer RN, Mowla A. Zambrano Espinoza MD, et al. Among authors: vaughn cb. Cerebrovasc Dis. 2021;50(2):141-146. doi: 10.1159/000511489. Epub 2021 Jan 8. Cerebrovasc Dis. 2021. PMID: 33423033

6

Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.

Mowla A, Memon A, Razavi SM, Lail NS, Vaughn CB, Mohammadi P, Sawyer RN, Shirani P. Mowla A, et al. Among authors: vaughn cb. J Stroke Cerebrovasc Dis. 2021 May;30(5):105678. doi: 10.1016/j.jstrokecerebrovasdis.2021.105678. Epub 2021 Feb 26. J Stroke Cerebrovasc Dis. 2021. PMID: 33640783

7

Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis.

Jakimovski D, Zivadinov R, Vaughn CB, Ozel O, Weinstock-Guttman B. Jakimovski D, et al. Among authors: vaughn cb. J Neurol Sci. 2021 Aug 15;427:117552. doi: 10.1016/j.jns.2021.117552. Epub 2021 Jun 23. J Neurol Sci. 2021. PMID: 34175775

8

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.

Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB, Zivadinov R. Jakimovski D, et al. Among authors: vaughn cb. J Neurol Sci. 2018 Oct 15;393:128-134. doi: 10.1016/j.jns.2018.08.020. Epub 2018 Aug 23. J Neurol Sci. 2018. PMID: 30165291

9

Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study.

Alex A, Vaughn C, Rayhill M. Alex A, et al. Headache. 2020 Nov;60(10):2454-2462. doi: 10.1111/head.13956. Epub 2020 Sep 23. Headache. 2020. PMID: 32969035

10

Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory study.

Jakimovski D, Ahmed MK, Vaughn CB, Zivadinov R, Weinstock-Guttman B. Jakimovski D, et al. Among authors: vaughn cb. Mult Scler Relat Disord. 2020 Jul;42:102131. doi: 10.1016/j.msard.2020.102131. Epub 2020 Apr 28. Mult Scler Relat Disord. 2020. PMID: 32408150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters